While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Novavax NVAX announced that it has agreed to sell its manufacturing facility ... sale opportunities for the plant to save operating costs. If the deal with Novo Nordisk goes through, the company ...

The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

Novo Nordisk (NVO), the company behind Ozempic and Wegovy, announced that it will invest 6.4 billion reais (about $1.09 ...

Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.

Novo Nordisk ) is going big in Brazil. The drugmaker behind Ozempic and Wegovy just dropped a $1.09 billion investment to ...

In accordance with the trilateral agreement, after approval by the FTC, Novo Nordisk will buy three Catalent plants from Novo Holdings for $11.7 billion. In particular, the deal includes plants in ...

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 billion) in 2024, it said on ...

It subsequently sold three Catalent manufacturing plants to Novo Nordisk for $11 billion to boost Wegovy production. However, total assets under management dropped slightly to 142 billion euros in ...